iVeena

company

About

iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.99K
Industries
Biotechnology,Clinical Trials,Life Science,Medical Device
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma.

iVeena Delivery Systems, Inc. was founded in 2006 by Bala Ambati and is based in Salt Lake City, Utah.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$2.12M
iVeena has raised a total of $2.12M in funding over 2 rounds. Their latest funding was raised on Jul 10, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 10, 2017 Grant $224.99K 1 National Science Foundation Detail
Dec 18, 2015 Seed $600K 2 Detail
Sep 25, 2015 Seed $1.30M 1 Park City Angels Detail

Investors

Number of Lead Investors
Number of Investors
2
3
iVeena is funded by 3 investors. National Science Foundation and Park City Angels are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Park City Angels Seed
PC Squared, LLC Seed